Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

AUTOR(ES)

DiRienzo, J M

RESUMO

Hybridoma cell lines which produce monoclonal antibodies to a leukotoxin from Actinobacillus actinomycetemcomitans were prepared. The monoclonal antibodies were selected for their ability to neutralize the cytotoxic activity of the leukotoxin and recognize the toxin on nitrocellulose blots. The antibodies belonged to either the immunoglobulin G1 (IgG1) or IgG2 subclass and differed in their ability to bind to the leukotoxin on nitrocellulose blots. However, only slight differences in neutralization titers were observed. Use of the monoclonal antibodies revealed that polymyxin B-extracted or osmotic shock-released leukotoxin could be separated into several high-molecular-weight polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Immunoblot analysis with the monoclonal antibodies also demonstrated that the leukotoxin was present in eight oral strains of A. actinomycetemcomitans that had been previously classified by a biological assay as leukotoxic. The availability of these monoclonal antibodies should facilitate and expand studies concerning the role of the leukotoxin in the pathogenicity of A. actinomycetemcomitans.

Documentos Relacionados

• Monoclonal antibodies to Actinobacillus actinomycetemcomitans.
• Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.
• Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.
• Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.
• A bacteriocin of Actinobacillus actinomycetemcomitans.